| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10687258 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 1060 journal articles in the PubMed database | Email to a friend | | |
| Cice G, Ferrara L, Tagliamonte E, et al.
[Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan] [Clinical Trial, Journal Article, Randomized Controlled Trial]
Cardiologia 1999 Dec; 44(12):1071-6.
Abstract | Full Citation | Find Related Articles | | Asmar R, Lacourcière Y
A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Hypertens 2000 Nov; 18(11):1683-90.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gradman AH, Lewin A, Bowling BT, et al.
Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Heart Dis 1999 May-Jun; 1(2):52-7.
Abstract | Full Citation | Find Related Articles | | Palma Gámiz JL, Pêgo M, Contreras EM, et al.
A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: The Iberian Multicenter Imidapril study on hypertension (IMISH). [Journal Article]
Clin Ther 2006 Dec; 28(12):2040-51.
Abstract | Full Citation | Find Related Articles | | Ohma KP, Milon H, Valnes K
Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Blood Press 2000; 9(4):214-20.
Abstract | Full Citation | Find Related Articles | | Baguet JP, Nisse-Durgeat S, Mouret S, et al.
A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring. [Journal Article]
Int J Clin Pract 2006 Apr; 60(4):391-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lacourcière Y, Neutel JM, Schumacher H
Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. [Journal Article, Meta-Analysis]
Clin Ther 2005 Nov; 27(11):1795-805.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Fukui T, Rahman M, Hayashi K, et al.
Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods. [Journal Article, Review]
Hypertens Res 2003 Dec; 26(12):979-90.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mallion J, Siche J, Lacourcière Y
ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Hum Hypertens 1999 Oct; 13(10):657-64.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
